Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Spain moves to decentralise medtech R&D (research and development) with new E9 million centre:

This article was originally published in Clinica

Executive Summary

Spain is to establish a new national regenerative medicine research centre in Barcelona, in line with a new national policy to decentralise healthcare R&D. Under an agreement signed between the Spanish health ministry and the Catalan regional government, the centre will be responsible for creating stem cell lines of embryonic and adult origin, as part of a national R&D programme that it will be responsible for devising in this area. The centre will be based at the biomedical research park of Barcelona (RRBB) and receive central funding totalling euro9m ($10.9m) by 2007.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts